Nicotine dependence predicts repeated use of prescribed opioids. Prospective population-based cohort study

Annals of Epidemiology

Volumn 20, Issue 12, 2010, Pages 890-897

  Skurtveit, Svetlana ^a,b   Furu, Kari ^a   Selmer, Randi ^a   Handal, Marte ^a   Tverdal, Aage ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Non Cancer Patients; Prescribed Opioids, Prospective Cohort Study; Smoking

Indexed keywords

NICOTINE; OPIATE DERIVATIVE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; OPIATE ADDICTION; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TOBACCO DEPENDENCE;

ADULT; AGED; ANALGESICS, OPIOID; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATABASES, FACTUAL; DRUG UTILIZATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NORWAY; OPIOID-RELATED DISORDERS; PAIN; PRESCRIPTION DRUGS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SMOKING; TOBACCO USE DISORDER;

EID: 78149467041     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2010.03.010     Document Type: Article

References (53)

1. Chou R., Fanciullo G.J., Fine P.G., Adler J.A., Ballantyne J.C., Davies P., et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009, 10:113-130.
2. Collins A, Simpson K. Recommendations for the appropriate use of opioids for persistent non-cancer pain. A consensus statement prepared on behalf of the Pain Society, the Royal College of Anaesthetists, the Royal College of General Practitioners and the Royal College of Psychiatrists. The British Pain Society; 2004;9. Available at: Accessed February 10, 2009. http://www.britishpainsociety.org/opioids_doc_2004.pdf.
3. Kalso E., Allan L., Dellemijn P.L., Faura C.C., Ilias W.K., Jensen T.S., et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 2003, 7:381-386.
4. Hojsted J., Sjogren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 2007, 11:490-518.
5. Akbik H., Butler S.F., Budman S.H., Fernandez K., Katz N.P., Jamison R.N. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage 2006, 3:287-293.
6. McLellan A.T., Turner B. Prescription opioids, overdose deaths, and physician responsibility. JAMA 2008, 300:2672-2673.
7. Turk D.C., Swanson K.S., Gatchel R.J. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain 2008, 24:497-508.
8. Gilson A.M., Ryan K.M., Joranson D.E., Dahl J.L. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage 2004, 28:176-188.
9. Joranson D.E., Ryan K.M., Gilson A.M., Dahl J.L. Trends in medical use and abuse of opioid analgesics. JAMA 2000, 283:1710-1714.
10. Sullivan M.D., Edlund M.J., Zhang L., Unutzer J., Wells K.B. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 2006, 166:2087-2093.
11. Simoni-Wastila L. Increases in opioid medication use: balancing the good with the bad. Pain 2008, 138:245-246.
12. Goldberg M.S., Scott S.C., Mayo N.E. A review of the association between cigarette smoking and the development of nonspecific back pain and related outcomes. Spine 2000, 25:995-1014.
13. Warner D.O. Perioperative abstinence from cigarettes: physiologic and clinical consequences. Anesthesiology 2006, 104:356-367.
14. Zarrindast M.R., Khoshayand M.R., Shafaghi B. The development of cross-tolerance between morphine and nicotine in mice. Eur Neuropsychopharmacol 1999, 9:227-233.
15. Biala G., Weglinska B. Calcium channel antagonists attenuate cross-sensitization to the rewarding and/or locomotor effects of nicotine, morphine and MK-801. J Pharm Pharmacol 2004, 56:1021-1028.
16. Shippenberg T.S., Heidbreder C., Lefevour A. Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur J Pharmacol 1996, 299:33-39.
17. Vihavainen T., Piltonen M., Tuominen R.K., Korpi E.R., Ahtee L. Morphine-nicotine interaction in conditioned place preference in mice after chronic nicotine exposure. Eur J Pharmacol 2008, 587:169-174.
18. Spiga R., Schmitz J., Day J. Effects of nicotine on methadone self-administration in humans. Drug Alcohol Depend 1998, 50:157-165.
19. Bjartveit K., Tverdal A. Health consequences of smoking 1-4 cigarettes per day. Tob Control 2005, 14:315-320.
20. Vollset S.E., Tverdal A., Gjessing H.K. Smoking and deaths between 40 and 70 years of age in women and men. Ann Intern Med 2006, 144:381-389.
21. Ekholm O., Gronbaek M., Peuckmann V., Sjogren P. Alcohol and smoking behavior in chronic pain patients: The role of opioids. Eur J Pain 2009, 13:606-612.
22. Michna E., Ross E.L., Hynes W.L., Nedeljkovic S.S., Soumekh S., Janfaza D., et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage 2004, 28:250-258.
23. Norwegian Health Surveys. Norwegian Institute of Public Health. Available at: Accessed February 10, 2009. http://www.fhi.no/eway/default.aspx?pid=238&trg=MainArea_5811&MainArea_5811=5895:0:15,4225:1:0:0:::0:0.
24. Naess O., Sogaard A.J., Arnesen E., Beckstrom A.C., Bjertness E., Engeland A., et al. Cohort profile: cohort of Norway (CONOR). Int J Epidemiol 2008, 37:481-485.
25. Skurtveit S., Furu K., Bramness J.G., Tverdal A. Benzodiazepine use in all alcohol consumers predicts use of opioids in patients 20 years later-a follow-up study of 13,390 men and women aged 40-42 years. Pharmacoepidemiol Drug Saf 2008, 17:926-933.
26. Sullivan M.D., Edlund M.J., Steffick D., Unutzer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain 2005, 119:95-103.
27. Søgaard A.J., Bjelland I., Tell G.S., Røysamb E. A comparison of the CONOR Mental Health Index to the HSCL-10 and HADS. Nor J Epidemiol 2003, 13:279-284.
28. Furu K. Establishment of the nationwide Norwegian Prescription Database (NorPD) - New opportunities for research in pharmacoepidemiology in Norway. Nor J Epidemiol 2008, 2:129-136.
29. ATC classification index with DDDs 2007. Norwegian Institute of Public Health 2006, WHO Collaboration Centre for Drug Statistics Methodology.
30. Bachs L., Engeland A., Morland J., Skurtveit S. The risk of motor vehicle accidents involving drivers with prescriptions for codeine or tramadol. Clin Pharmacol Ther 2009, 85:596-599.
31. Ballantyne J.C., LaForge K.S. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007, 129:235-255.
32. Cicero T.J., Lynskey M., Todorov A., Inciardi J.A., Surratt H.L. Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain 2008, 139:127-135.
33. Franklin G.M., Mai J., Wickizer T., Turner J.A., Fulton-Kehoe D., Grant L. Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002. Am J Ind Med 2005, 48:91-99.
34. Tetrault J.M., Desai R.A., Becker W.C., Fiellin D.A., Concato J., Sullivan L.E. Gender and non-medical use of prescription opioids: results from a national US survey. Addiction 2008, 103:258-268.
35. Stover B.D., Turner J.A., Franklin G., Gluck J.V., Fulton-Kehoe D., Sheppard L., et al. Factors associated with early opioid prescription among workers with low back injuries. J Pain 2006, 7:718-725.
36. Eriksen J., Sjogren P., Bruera E., Ekholm O., Rasmussen N.K. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain 2006, 125:172-179.
37. Pedersen W., von Soest T. Smoking, nicotine dependence and mental health among young adults: a 13-year population-based longitudinal study. Addiction 2009, 104:129-137.
38. Welcome to the Norwegian Prescription Database. Norwegian Institute of Public Health. Available at: Accessed February 10, 2009. http://www.fhi.no/eway/default.aspx?pid=238&trg=MainArea_5811&MainArea_5811=5903:0:15,4440:1:0:0:::0:0.
39. Fredheim O.M.S., Skurtveit S., Moroz A., Breivik H., Borchgrevink P.C. Prescription pattern of codeine for non-malignant pain: a pharmacoepidemiological study from the Norwegian Prescription Database. Acta Anaesthesiol Scand 2009, 53:627-633.
40. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993, 18:247-291.
41. Corrigall W.A., Franklin K.B., Coen K.M., Clarke P.B. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 1992, 107:285-289.
42. Shippenberg T.S., Bals-Kubik R., Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther 1993, 265:53-59.
43. Vihavainen T., Relander T.R., Leiviska R., Airavaara M., Tuominen R.K., Ahtee L., et al. Chronic nicotine modifies the effects of morphine on extracellular striatal dopamine and ventral tegmental GABA. J Neurochem 2008, 107:844-854.
44. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 1992, 12:483-488.
45. Warner D.O. Tobacco dependence in surgical patients. Curr Opin Anaesthesiol 2007, 20:279-283.
46. Benowitz N.L. Nicotine and postoperative management of pain. Anesth Analg 2008, 107:739-741.
47. Flood P., Daniel D. Intranasal nicotine for postoperative pain treatment. Anesthesiology 2004, 101:1417-1421.
48. Habib A.S., White W.D., El Gasim M.A., Saleh G., Polascik T.J., Moul J.W., et al. Transdermal nicotine for analgesia after radical retropubic prostatectomy. Anesth Analg 2008, 107:999-1004.
49. Hong D., Conell-Price J., Cheng S., Flood P. Transdermal nicotine patch for postoperative pain management: a pilot dose-ranging study. Anesth Analg 2008, 107:1005-1010.
50. Biala G., Weglinska B. On the mechanism of cross-tolerance between morphine- and nicotine-induced antinociception: Involvement of calcium channels. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:15-21.
51. Fleming R., Leventhal H., Glynn K., Ershler J. The role of cigarettes in the initiation and progression of early substance use. Addict Behav 1989, 14:261-272.
52. Kandel D.B., Yamaguchi K., Chen K. Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. J Stud Alcohol 1992, 53:447-457.
53. Kalso E., Edwards J.E., Moore R.A., McQuay H.J. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004, 112:372-380.